How to use the speech recognition tool?
Dose-escalation Study to Evaluate the Safety and Tolerability of GS030 in Subjects
With Retinitis Pigmentosa (PIONEER).
Status of the trial: Recruiting
Orphan Drug Recognition: No
Funder Type: industry
Principal location of the trial
HCP: Principal investigators
HCP: Other investigators